Callan Family Office’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Buy
8,847
+203
+2% +$6.55K 0.01% 1028
2026
Q1
$212K Sell
8,644
-2,984
-26% -$71K ﹤0.01% 1047
2025
Q4
$219K Buy
+11,628
New +$193K ﹤0.01% 1030

Other funds holding CSTM

Callan Family Office's CSTM Position: Q2 2026 in Review

Callan Family Office increased its Constellium (CSTM) stake by 2.3% in Q2 2026, buying an estimated $6.55K and bringing the position to 8,847 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #1028.

Callan Family Office first reported a position in CSTM in Q4 2025 and has held it in 3 quarters since. 390 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Callan Family Office held 8,847 shares of Constellium worth $282K as of Q2 2026.
  • Callan Family Office bought 203 Constellium shares in Q2 2026, an estimated $6.55K.
  • Constellium made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #1028 holding.
  • Callan Family Office first reported a position in Constellium in Q4 2025 and has held it in 3 quarters since.
  • 390 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.